Journal of Investigative Medicine High Impact Case Reports (Dec 2017)

Mixed Adenoneuroendocrine Carcinoma of the Gastroesophageal Junction: A Rare Find

  • Paurush Ambesh MD,
  • Joseph Weissbrot MD,
  • Sabina Ratner MD,
  • Ankur Sinha MD,
  • Ravikaran Patti MD,
  • Jasminka Balderacchi MD,
  • Michael Marcelin MD,
  • Lawrence Wolf MD,
  • Stephan Kamholz MD

DOI
https://doi.org/10.1177/2324709617750180
Journal volume & issue
Vol. 5

Abstract

Read online

Neoplastic lesions that demonstrate neuroendocrine features are rare. However, esophageal tumors containing both adenocarcinomatous and neuroendocrine components are exceedingly rare. Mixed adenoneuroendocrine carcinomas (MANECs) are gastrointestinal tumors with both adenocarcinomatous and neuroendocrine differentiation. They have a tendency for early metastases but clinically manifest relatively late. Imaging studies are often nonspecific with regard to tumor type, and a histopathologic study of biopsy material is required for definitive diagnosis. The overall prognosis is poor. The current report describes a rare case of gastroesophageal MANEC tumor, with approximately 60% neuroendocrine and 40% adenocarcinomatous components. Since there is a dearth of concrete management guidelines for MANECs, we present possible management options to add to the existing literature.